Serial #90351202
LIVE

Serial Number

90351202

Owner

Avita Drugs, LLC

Attorney

Mary Mazzello

First Use Date

Mar 11, 2021

Filing Date

Dec 1, 2020

Add to watchlist:

No watchlists yet
View on USPTO

Serial #90351202 Trademark

Serial Number: 90351202 • Registration: 6755364

Serial #90351202 is a trademark filed by Avita Drugs, LLC on December 1, 2020. The trademark is classified under Class 36 (Insurance & Financial), Class 39 (Transportation & Storage), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Avita Drugs, LLC (23 trademarks)

Baton Rouge, LA 70808

Entity Type: 16

Trademark Details

Filing Date

December 1, 2020

Registration Date

June 7, 2022

First Use Anywhere

March 11, 2021

First Use in Commerce

March 11, 2021

Published for Opposition

June 29, 2021

Goods & Services

Prescription delivery services, administration and management of third party use of the federal 340B prescription drug discount program, namely, medication delivery services, and delivery and packing of goods for transport purposes pursuant to compliance regulations

Facilitating and coordinating insurance authorization for prescriptions between and among patients, doctors, care-givers and insurance, and communicating with patients regarding prescription cost and insurance coverage of prescription drugs; administration and management of third party use of the federal 340B prescription drug discount program, namely, bill payment services and debt collections services

Pharmacy services, namely, coordinating filling and refilling prescriptions, generating reports to patients, prescribers, and care givers regarding prescriptions, and assisting with pharmaceutical drug billing; retail pharmacy services; pharmaceutical cost management advisory and consulting services and drug utilization review advisory and consulting services, namely, enhancing access to low-cost pharmaceuticals for the medically underserved and supporting not-for-profit hospitals and health centers in administering and maximizing the use of the federal 340B prescription drug discount program to reduce pharmaceutical costs and improve the health status of their patients; administration and management of third party use of the federal 340B prescription drug discount program, namely, assisting with registration, reporting, business auditing, coordination and assignment of benefits, medication inventory management; pharmacy discount card services, namely, administration of a discount programs for enabling participants to obtain discounts on pharmaceutical goods through the use of a discount membership card; retail pharmacy services, namely, 340B contract pharmacy services

Patient medication care management and medication adherence services, namely, counseling patients regarding their medications, adherence to medication regimens, medication side-effects, allergic sensitivity, drug interactions, or other issues related to medication tolerance, alternate medication brands or generics, dosage or manner of taking medications; coordinating and implementing information and instructions regarding patients' medication regimen and adherence thereto, medication needs and issues, consideration of generic or alternative medications, between and among patients, doctors, care-givers and insurance; coordinating patient medication care management information and facilitating adherence to medication regimens, between and among patients, doctors, care-givers and insurance; dispensing medication under the federal 340B prescription drug discount program; administration and management of third party use of the federal 340B prescription drug discount program, namely, medication services in the nature of administration of medication medicating to patients and prescription refill reminder services

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sep 2, 2025 ASCK
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 21, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 21, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 21, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 21, 2024 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 7, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 7, 2022 R.PR
ASSIGNED TO EXAMINER
May 27, 2022 DOCK
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 3, 2022 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 2, 2022 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 22, 2022 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 22, 2022 AITU
USE AMENDMENT FILED
Feb 24, 2022 IUAF
TEAS STATEMENT OF USE RECEIVED
Feb 24, 2022 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 16, 2022 EXRA
SOU EXTENSION 1 GRANTED
Feb 14, 2022 EX1G
SOU EXTENSION 1 FILED
Feb 14, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 14, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 24, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 29, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 29, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 9, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 21, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
May 21, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 21, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
May 21, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 21, 2021 CNEA
ASSIGNED TO EXAMINER
May 17, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 6, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 5, 2021 NWOS
NEW APPLICATION ENTERED
Dec 4, 2020 NWAP